Novo Nordisk stock pre-market at EUR 35.04

Published on 10/16/2026 at 07:59 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Novo Nordisk stock is at EUR 35.04 pre-market at Lang & Schwarz on October 16, 2026. The company’s next financial-results announcement is scheduled for November 4, 2026.

Dates and trading context ahead

Novo Nordisk's next financial-results announcement is scheduled for November 4, 2026.
Novo Nordisk stock trades pre-market at EUR 35.04 at 7:56 a.m. CEST at Lang & Schwarz on October 16, 2026.
The investor-relations calendar lists the second-quarter 2026 results announcement on August 4, 2026.

Kopenhagener Hafen mit Brücken, Aquarell in Pastelltönen, nordische Atmosphäre — Novo Nordisk A/S (DK0062498333): Kopenhagener Hafenpanorama mit historischen Brücken in weichen Aquarell-Pastelltönen gemalt, Illustration mit AI erstellt.

Novo Nordisk stock is at EUR 35.04 pre-market at Lang & Schwarz on October 16, 2026, with the quote recorded at 7:56 a.m. CEST.

Pre-market trading

The bid was EUR 34.96 and the ask was EUR 35.13. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Novo Nordisk stock.

What matters today

The next scheduled financial-results announcement is on November 4, 2026, at 7:30 a.m. CEST, according to Novo Nordisk's investor-relations calendar. The calendar lists the second-quarter 2026 results announcement on August 4, 2026. Novo Nordisk hosted its Capital Markets Day on September 21, 2026, in London.

Novo Nordisk states that its next financial-results announcement will cover the first three quarters of 2026. The company also identifies Novo Nordisk A/S as the issuer on its investor-relations page.

Market context: Market report Euro Stoxx 50.

More news and analysis on Novo Nordisk stock